文献速递白血病

重金属基线评分可预测急性髓系白血病预后

A heavy metal baseline score predicts outcome in acute myeloid leukemia.
PubMed 文献 · Am J Hematol · 2020-03-04

该研究在里昂民众医院检测了67例未经治疗的急性髓系白血病(AML)患者和94例对照者的血清金属水平及铜同位素丰度比,发现多数金属值在两组间差异显著。

要点

  • 该金属评分在独立前线AML人群中同样具有预后价值

核心结论

  • 未经治疗AML患者的基线血清金属值与对照者存在显著差异。
  • 低镁合并高镉与AML患者最差生存相关,且在多变量分析中保持独立预后意义。
  • 基于五种有毒金属和五种必需金属构建的基线金属评分可预测AML患者生存,并在独立前线AML人群中验证。

研究设计与样本

  • 研究纳入里昂民众医院67例未经治疗的AML患者和94例对照者。
  • 采用电感耦合等离子体质谱法检测血清痕量金属和铜同位素丰度比。
  • 生存分析按金属值进行,并开发多金属评分。
  • 多数AML患者为中等风险细胞遗传学(63.1%),无FLT3内部串联重复突变(75.6%)或无NPM1突变(68.1%)。

主要发现

  • AML组与对照组之间多数金属值存在显著差异。
  • 该不良预后组合在多变量分析中保持显著。
  • 该金属评分在独立前线AML患者人群中同样具有预后价值。

关键数值与推荐

  • 金属评分基于五种有毒金属和五种必需金属的相对异常。

临床怎么用

  • 基线血清金属评分或可作为AML患者预后分层工具。
  • 低镁和高镉组合提示不良生存风险,需加强关注。
  • 该评分在独立前线AML人群中验证,提示潜在通用性。

局限性

  • 样本量有限(67例AML和94例对照)。
  • 单中心研究,外部验证队列规模未报告。
  • 金属值与生存关联的机制未阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite abundant epidemiological data linking metals to leukemia and other cancers, baseline values of toxic and essential metals in patients with leukemia and the clinical impact of these metals remain unknown. Thus, we sought to quantify metal values in untreated patients with acute myeloid leukemia (AML) and controls and determine the impact of metal values on AML patients' survival. Serum samples from patients with untreated AML and controls at Hospices Civils de Lyon were analyzed and compared for trace metals and copper isotopic abundance ratios with inductively coupled plasma mass spectrometry. Survival analysis was performed as a function of metal values, and a multi-metal score was developed for patients with AML. Serum samples were collected from 67 patients with untreated AML and 94 controls. Most patients had intermediate-risk cytogenetics (63.1%) without FLT3 internal tandem duplication mutations (75.6%) or NPM1 mutations (68.1%). Most metal values differed significantly between AML and control groups. Patients with lower magnesium and higher cadmium values had the worst survival rates, with only 36% surviving at 6 months (P = .001). The adverse prognostic effect of this combination was maintained on multivariate analysis. Based on this, we developed a novel metal score, which accounts for multiple relative abnormalities in the values of five toxic and five essential metals. Patients with a higher metal score had significantly worse survival, which was maintained on multivariate analysis (P = .03). This baseline metal scoring system was also prognostic when we applied it to a separate population of front-line AML patients.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Ohanian M, Telouk P, Kornblau S, et al. A heavy metal baseline score predicts outcome in acute myeloid leukemia. Am J Hematol. 2020. PMID: 31944361. doi:10.1002/ajh.25731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。